Rolla S - Search Results

1

Lower Multiple Sclerosis Severity Score Is Associated with Higher Adherence to Mediterranean Diet in Subjects with Multiple Sclerosis from Northwestern Italy.

Bronzini M, Maglione A, Rosso R, Masuzzo F, Matta M, Meroni R, Rolla S, Clerico M. Bronzini M, et al. Among authors: rolla s. Nutrients. 2024 Mar 18;16(6):880. doi: 10.3390/nu16060880. Nutrients. 2024. PMID: 38542790 Free PMC article.

2

Feeding the gut microbiome: impact on multiple sclerosis.

Bronzini M, Maglione A, Rosso R, Matta M, Masuzzo F, Rolla S, Clerico M. Bronzini M, et al. Among authors: rolla s. Front Immunol. 2023 May 25;14:1176016. doi: 10.3389/fimmu.2023.1176016. eCollection 2023. Front Immunol. 2023. PMID: 37304278 Free PMC article. Review.

3

The Adaptive Immune System in Multiple Sclerosis: An Estrogen-Mediated Point of View.

Maglione A, Rolla S, Mercanti SF, Cutrupi S, Clerico M. Maglione A, et al. Among authors: rolla s. Cells. 2019 Oct 19;8(10):1280. doi: 10.3390/cells8101280. Cells. 2019. PMID: 31635066 Free PMC article. Review.

4

The Meaning of Immune Reconstitution after Alemtuzumab Therapy in Multiple Sclerosis.

Rolla S, Maglione A, De Mercanti SF, Clerico M. Rolla S, et al. Cells. 2020 Jun 3;9(6):1396. doi: 10.3390/cells9061396. Cells. 2020. PMID: 32503344 Free PMC article. Review.

5

Host Genetics and Gut Microbiome: Perspectives for Multiple Sclerosis.

Maglione A, Zuccalà M, Tosi M, Clerico M, Rolla S. Maglione A, et al. Among authors: rolla s. Genes (Basel). 2021 Jul 29;12(8):1181. doi: 10.3390/genes12081181. Genes (Basel). 2021. PMID: 34440354 Free PMC article. Review.

6

Humoral response after the booster dose of anti-SARS-CoV-2 vaccine in multiple sclerosis patients treated with high-efficacy therapies.

Maglione A, Morra M, Meroni R, Matta M, Clerico M, Rolla S. Maglione A, et al. Among authors: rolla s. Mult Scler Relat Disord. 2022 May;61:103776. doi: 10.1016/j.msard.2022.103776. Epub 2022 Mar 26. Mult Scler Relat Disord. 2022. PMID: 35364386 Free PMC article.

7

Long-lasting neutralizing antibodies and T cell response after the third dose of mRNA anti-SARS-CoV-2 vaccine in multiple sclerosis.

Maglione A, Francese R, Arduino I, Rosso R, Matta M, Rolla S, Lembo D, Clerico M. Maglione A, et al. Among authors: rolla s. Front Immunol. 2023 Jun 19;14:1205879. doi: 10.3389/fimmu.2023.1205879. eCollection 2023. Front Immunol. 2023. PMID: 37409134 Free PMC article.

8

Computational modeling of the immune response in multiple sclerosis using epimod framework.

Pernice S, Follia L, Maglione A, Pennisi M, Pappalardo F, Novelli F, Clerico M, Beccuti M, Cordero F, Rolla S. Pernice S, et al. Among authors: rolla s. BMC Bioinformatics. 2020 Dec 14;21(Suppl 17):550. doi: 10.1186/s12859-020-03823-9. BMC Bioinformatics. 2020. PMID: 33308135 Free PMC article.

9

Long-Term Effects of Alemtuzumab on CD4+ Lymphocytes in Multiple Sclerosis Patients: A 72-Month Follow-Up.

Rolla S, De Mercanti SF, Bardina V, Maglione A, Taverna D, Novelli F, Cocco E, Vladic A, Habek M, Adamec I, Annovazzi POL, Horakova D, Clerico M. Rolla S, et al. Front Immunol. 2022 Feb 28;13:818325. doi: 10.3389/fimmu.2022.818325. eCollection 2022. Front Immunol. 2022. PMID: 35296069 Free PMC article.

10

Long-term safety evaluation of natalizumab for the treatment of multiple sclerosis.

Clerico M, Artusi CA, Di Liberto A, Rolla S, Bardina V, Barbero P, De Mercanti SF, Durelli L. Clerico M, et al. Among authors: rolla s. Expert Opin Drug Saf. 2017 Aug;16(8):963-972. doi: 10.1080/14740338.2017.1346082. Epub 2017 Jul 5. Expert Opin Drug Saf. 2017. PMID: 28641055 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50 results

Search Page

Filters